Results 131 to 140 of about 1,655,298 (265)

Skin marker for MR-only surface high-dose-rate brachytherapy

Journal of Contemporary Brachytherapy
Evangelia Kaza, Phillip M. Devlin, Desmond O’Farrell, Ivan Buzurovic   +3 more
doaj   +1 more source

Development of a low-cost 3D-printed phantom for end-to-end testing of model-based dose calculation algorithms (MBDCAs) in high-dose-rate (HDR) brachytherapy. [PDF]

J Appl Clin Med Phys
Grace S, Wang L, Cao Y, Huang L.
europepmc   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

Molecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani, Dominic Guanzon, Andrew Lai, Katherin Scholz‐Romero, Sarah Reed, Edita Ritmejeryte, Rohan Lourie, Naven Chetty, Kaltin Ferguson, Carlos Salomon   +9 more
wiley   +1 more source

High Dose Rate Brachytherapy(HDR BT) in Organ Confined Prostate Cancer

Apollo Medicine, 2008
P Mahadev, L S Ravishankar, P G G Kurup, V Murali, Jayraj , Bhagyam   +5 more
doaj   +1 more source

High-dose-rate monotherapy for localised prostate Cancer: A two-implant approach with median 13 years follow-up. [PDF]

Clin Transl Radiat Oncol
Best C, Spier V, Baltas D, Ackermann H, Rödel C, Zamboglou N, Tselis N.   +6 more
europepmc   +1 more source

A role for eIF5A in translational control of stress‐inducible proteins in multiple myeloma cell lines

Molecular Oncology, EarlyView.
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both, Ingrid A. M. Derks, Raphaël Vanleyssem, Marine Leclercq, Najla El Hachem, Pierre Close, Eric Eldering, Marco Vincent Haselager   +7 more
wiley   +1 more source

Endobronchial High-Dose-Rate Brachytherapy for Posttransplant-Associated Bronchial Stenosis: Extended Follow-up of Pulmonary Function and Subsequent Procedures. [PDF]

Adv Radiat Oncol
Schaar DA, Yohannes A, Groszkiewicz A, Iheagwara U, Johnson BA, Schuchert M, Li F, Houser C, Doraisamy E, Kim H, Burton SA, Vargo JA.   +11 more
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

Ultra-high dose rate dependent modeling of plasmid DNA damage with TOPAS-nBio. [PDF]

Phys Med Biol
Masilela TAM, D-Kondo JN, Shin WG, Rezaee M, LaVerne JA, Paganetti H, Faddegon B, Schuemann J, Ramos-Méndez J.   +8 more
europepmc   +1 more source